To blunt the aforementioned airway responses to tracheal extubation, lignocaine, a commonly used local anesthetic having an amide side chain can be used preoperatively through a different route of administration, thus reducing the severity of postoperative airway complications. [6] Lignocaine lozenge on a stick (like a lollipop) is a novel method of providing anesthesia in the oropharyngeal region by swallowing the saliva which is mixed with the local anesthetic resulting in a homogenous and slow spread of the drug, thereby providing adequate time for exerting its effects in the desired local site. [7] Lignocaine pneumatic nebulizers work on the principle of conversion of droplets into aerosols of smaller size (1-5 mm) by using baffles such as they can be inhaled. Nebulization is favored for being a safe and easy route of administration to the patients in addition to its benefit of drug reaching lower airways.
To the best of our knowledge, no previous study has compared the efficacy of lignocaine nebulization and lignocaine lozenges for direct laryngoscopic biopsy. Therefore, the present study was designed to evaluate the effect of lignocaine nebulization and lignocaine lozenges in patients undergoing direct laryngoscopy and biopsy under general anesthesia with tracheal intubation.
The aim of the present study was to evaluate and compare the effects of lignocaine administered by two different formulations on immediate postextubation respiratory complications (cough being the primary outcome) after the direct laryngoscopic biopsy.
SubjectS and MethodS

Patients
The study was conducted at Himalayan Hospital in the Department of Anaesthesiology after obtaining the Institutional Ethics Committee approval (RBR number-SRHU/HIMS/ ETHICS/2018/78 Dated 13.07.2018) and written informed consent of patients. A total of 90 inpatients, aged 40-70 years of either sex, ASA physical status Classes I, II, and III, posted for elective direct laryngoscopic biopsy requiring general anesthesia with endotracheal intubation, were included in the study.
Exclusion criteria
Patients refusal for the procedure, weight <40 kg, patients requiring re-intubation or tracheostomy, history of active upper respiratory tract infection, Mallampatti grade III and above were excluded from the study. Patients were also excluded if there was a history of allergy to lignocaine, hepatic, renal or cardiopulmonary insufficiency, alcoholic, diabetes, long-term analgesic therapy.
Study protocol Type of the study
This was randomized, experimental study. Sample size and sampling methods-Sample size calculation was based on data analyzed in similar studies performed in the past using G * Power (Version 3.2.1, Germany). Sample size estimation was based on cough (primary outcome) presuming the proportion of reduction in the incidence of cough postextubation was 78% in the study group. The total sample size was calculated to be 90 (30 patients in each group) from an effect size of 0.67, power of 80%, and α of 0.05 to detect the significant difference (P < 0.05) between any two groups. [8] Method of randomization: Randomization block design was used to randomize 90 patients who fulfil the inclusion and exclusion criteria among three groups such that each group had 30 patients. The randomized block size was 9.
Method of anesthesia
All the eligible patients were asked to refrain from smoking for at least 48 h before surgery and were kept nil per oral for solids for 6 h. tablet (tab) ranitidine 150 mg and tab alprazolam 0.25 mg were administered night before and 2 h before surgery.
Patients were divided into three groups:
Group A: Patients receiving lignocaine nebulization were explained the procedure and were nebulized with 4% lignocaine 200 mg (5 mL) through ultrasonic nebulizer 20 min before surgery.
Group B: Patients were explained about the procedure and were given lignocaine lozenge 200 mg to suck and not to swallow or chew the lozenge at least 20 min before being taken for surgery.
Group C: Patients were taken up for surgery without any intervention.
In the operation room after establishing intravenous access and applying mandatory monitoring, anesthesia in all the cases was induced with injection fentanyl 2 µg/kg and injection propofol 2 mg/kg till the loss of verbal contact. Ease of bag-mask ventilation was assessed and neuromuscular blockade established with injection succinylcholine 2 mg/kg. The patients were ventilated with 66% nitrous oxide (N 2 O) in oxygen (O 2 ) and sevoflurane. Endotracheal intubation was completed utilizing Laryngoscopy was done using Macintosh laryngoscope and EndoTracheal Tube (ETT) of appropriate size was used.
Intubation and endotracheal tube placement were confirmed by auscultation of the chest, SpO 2 >95% and capnogram recording. The duration of laryngoscopy and number of attempts were noted.
All the intubations were carried out by a single intubator with experience >2 years in anesthesia. Anesthesia was maintained with 66% N 2 O in O 2 , sevoflurane. With the resumption of spontaneous respiration, N 2 O was switched off, gentle suction was done, cuff of ETT deflated and the patient extubated once the patient gained consciousness and good spontaneous respiration. Harsh suctioning or bucking on ETT was avoided.
After extubation, cough was observed and graded by Harding and McVey [9] score [ Table 1 ] at different time intervals that is at extubation, after 5 min, then every 10 min till maximum of 30 min postextubation.
Data management and statistical analysis
Data were analyzed using Statistical Package for the Social science System version SPSS 20 (IBM Corp. Released 2011. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp). Qualitative data were expressed as frequency and percentage. Qualitative data followed normal distribution and were presented as mean ± standard deviation also skewed distribution, for example, duration was expressed as median (range). Categorical variables between the groups were compared using the Chi-squared test or Fisher's exact test as appropriate. Change in score in categorical variables was assessed using Stuart Maxwell test. The comparison of the normal and skewed distribution of continuous variables between the groups was performed using one-way analysis of variance and KruskalWallis H test, respectively. Bonferroni and Dunn multiple comparison tests were also used for intergroup comparison.
For all statistical tests, a value of P < 0.05 was taken to indicate a significant difference and value ≤0.01 was considered as highly significant.
reSultS
All the patients included completed the study [ Figure 1 ]. The demographic profile and intubation characteristics are depicted in Tables 2 and 3 and the three groups were comparable for age, sex, weight, duration of laryngoscopy, number of attempts, and duration of surgery and anesthesia (P > 0.05).
Post-extubation cough was scored on 4 point scale, After extubation, no cough was seen in 1 (3.3%) patients (Group A) compared to 2 (6.6%) in Group B and 1 (3.3%) in Group C. Severe cough (score 3) was present in 05 (16%) (Group A) compared to 8 (26.6%) (Group B) and 12 (40%) patient in Group C. Incidence of no cough increased to 4 (13.3%), 9 (30%), 10 (33%) patients after 5, 10, and 20 min, respectively, in Group A, similar trend was seen for patients in Group B, whereas in Group C, all patients had some intensity of cough.
After 30 min, no cough was found to be highly significant in the association of a cough with the passage of time (P < 0.05) [ Table 4 ].
Comparison of a cough at various time intervals starting from extubation up to 30 min in postextubation period was highly significant in between groups. However, severe postextubation cough was most common in control group (67%) followed by lignocaine nebulization group (47%) with least common occurrence in lignocaine lozenges group (40%) [ Figure 2 ].
dIScuSSIon
Just like any foreign-body and medical procedure, tracheal intubation can cause iatrogenic trauma to oro-laryngo-tracheal structures. Moreover, when surgical procedures (diagnostic or interventional) are concomitantly performed on these structures, the incidence of symptoms related to iatrogenic trauma may increase.
It has already been documented by Tanaka et al. that laryngeal reflexes' attenuation happens even with laryngeal mask airway insertion despite no "foreign body" (tube) traversing through the larynx and into the trachea; however, changes in laryngeal reflexes induced by tracheal tubes were significantly measurable. [10] Therefore, the present research was designed to explore (a) if postoperative symptoms as related to iatrogenic trauma of oro-laryngo-tracheal structures increase with concomitant tracheal intubation by anesthesiologists and laryngoscopic biopsy by oto-rhino-laryngologists and (b) whether two different formulations of lignocaine differentially effect the incidence of these symptoms.
Study conducted by Gupta et al. concluded that the incidence of cough had decreased from 54% with placebo to 22% with Strepsils ® given preoperatively. [8] Banihashem et al. conducted a study and found that incidence of cough within one hour of extubation was effectively reduced when their tracheal tubes had been sprayed with 10% lidocaine (17% cough incidence) or 50% beclomethasone (0% cough incidence) prior to intubation as compared to if their tracheal tubes had been sprayed with placebo (normal saline; 33% cough incidence). [11] In this study, comparison of cough at various time intervals starting from extubation up to 30 min in postextubation period was highly significant in between groups. Among Group A (lignocaine nebulization), 33% of patients had a decrease in severity of cough within the first 5 min; although among Group B (lignocaine lozenges), the decrease in the severity of cough was 40%. A similar decrease in the severity of cough was observed through various time interval from 10 min to 30 min postextubation. After 30 min, 73% of patients in Group A and 76% of patients in Group B had incidence of decrease in the severity of cough. Therefore, lignocaine lozenges were more effective in decreasing the severity of cough in comparison to Lignocaine nebulization. A remarkable finding was that occurrence of severe postextubation cough was most common in control group (67%) followed by lignocaine nebulization group (47%) with the least common incidence in lignocaine lozenges group (40%). such as a cough, sore throat, and hoarseness of voice. Two different formulations of lignocaine, which is nebulization and lozenges, are found to be effective in reducing airway complications.
Lignocaine lozenges have been found to have a better result in reducing cough than lignocaine nebulization. However, both lignocaine nebulization and lozenges demonstrated to be beneficial in improving airway outcome and in improving patient's satisfaction.
Limitations of study
The drawbacks in this study were, we did not record coughing and other airway complications beyond 30 min after extubation in the postoperative period.
We did not take into account the sedation score at the time of extubation. Therefore, patients' response could not be relied on precisely in terms of hoarseness and sore throat (interview method was used for assessment).
The further study can be planned to take into account the aforementioned limitations.
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